Budesonide-formoterol 160-4.5 10.2GM
Ended Awarded
- Contract number
- SPE2DB25FE1HU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,144
Award facts
- Contract value 100% obligated
- $89,144.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Budesonide-Formoterol 160-4.5 mg inhalation aerosol in a 10.2-gram container. This competitively awarded, non-set-aside contract carries a ceiling value of $89,144.39 and operates under firm fixed-price terms, with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a broad portfolio of pharmaceutical products and medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated capability across multiple therapeutic domains through consistent competitively awarded contracts with the DLA Medical Supply Chain. Budesonide-Formoterol is a combination corticosteroid-bronchodilator used in respiratory disease management, aligning with the military's ongoing need for maintenance inhalation therapies to support service member and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FE1HU?
SPE2DB25FE1HU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FE1HU worth?
The government has obligated $89,144 on SPE2DB25FE1HU.
Is contract SPE2DB25FE1HU an order under another contract?
Yes. SPE2DB25FE1HU is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1HU competed?
The extent of competition for SPE2DB25FE1HU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award